Monday 31 March 2014

Erythropoietin Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Erythropoietin is a type of a glycoprotein produced by body that controls red blood cell production in the body and is produced in kidneys. Kidney cells responsible for production of erythropoietin are sensitive to oxygen levels in the blood. Low levels of oxygen in the blood triggers the production and release of erythropoietin. Erythropoietin stimulates the bone marrow to produce red blood cells that ultimately carries oxygen and maintains the oxygen levels in the body. Thenormal range of erythropoietin is 4 to 24 mU/ml.


Erythropoietin tests detects abnormal levels of erythropoietin in the blood thus indicating kidney diseases, bone marrow disorders and excess erythropoietin production.Erythropoietin is also used to correct anemic conditions by stimulating red blood cell production.  Increasing incidences of anemia globally mainly resulting from chemotherapy and rapidly increasing morbidity rate of kidney disorders are driving the growth of the global erythropoietin market. While on the other hand, erythropoietin market has reached to saturation in developed countries thus restraining the growth of this market to some extent. Synthetic erythropoietin is produced using DNA recombinant technology. Erythropoietin market can be categorized on the basis of types of synthetic erythropoietin as follows:
  • Epoetin-alfa
  • Epoetin-beta
  • Epoetin-omega
  • Epoetin-delta
  • Darbepoetin-alfa

Further, based on application erythropoietin market is segmented as,
  • Oncology diseases
  • End stage renal disease (ESRD)
  • Pre-dialysis

Geographically the market is segmented into,
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Currently, North America dominatesthe erythropoietin market and is followed by Europe due high spending capacity in the healthcare infrastructure in these regions. Asia-Pacific is a promising market for erythropoietin and is expected to undergo rapid market growth due to increase in purchasing power, rapidly improving healthcare infrastructure and increased medical tourism and the available treatments. Some of the major companies contributing to this market include Hospira Inc., Amgen Inc., Roche Diagnostics and Johnson & Johnson.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse all Market Research Reports Blogs:

Thursday 27 March 2014

Enzyme-Linked Immunosorbent Assay Technologies Market - Global Industry, Trends And Forecast, 2013 - 2019

Enzyme-Linked Immunosorbent Assay (ELISA) is a test performed to detect the presence of antibodies in a biological liquid sample.  ELISA is used as quality control check in many industry and as a diagnostic tool in plant pathology and in medicine.

Though the latest emerging technology i.e. themultiplex proteomic array platform is rapidly replacing the ELISA, its market continues to grow since it is being preferred as a secondary validation tool to confirm the results of multiplex proteomic platform. Emergence of cost effective technologies and laboratory automation are some of the major factorsthat are driving the global ELISA market towards growth. The existing ELISA manufacturers are currently facing price pressures due to increase in the number of market players, thereby increasing competitive rivalry. In order to survive the market competition, many market players are have begun to shift their focus on niche marketsand have increased their efforts in developing innovative solutions.

The ELISA market can be segmented based on test types such as:
Sandwich ELISA
Indirect ELISA
Multiple and portable ELISA
Competitive ELISA
This market is further segmented on the basis of applications, such as:
Immunology
Inflammation
Infectious diseases
Cancer
Protein quantitation
Other

Geographically, the global enzyme-linked immunosorbent assay market can be categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America,particularly the United States currently leads this marketand is followed by Europe due to widespread existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for ELISA kits and is expected to undergo rapid market growth. Especially countries like China and India are promising regions, reason being rapidly growing medical tourism industry in India and China will increase the use of ELISA test as a diagnostic tool.

Some of the market players leading the enzyme-linked immunosorbent assay (ELISA) market include Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific. Inc., Life Technologies Corporation and ZEUS Scientific, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Thursday 13 March 2014

Natural Source Vitamin E Market - 2013 - 2019

Vitamin E is a significant antioxidant which helps against free-radicals and it can be conserved longer by the tissues in the body as compared to man-made vitamin E. Natural vitamins has seen increased demand from the end users in recent past. Natural source vitamin E includes tocopherols and tocotrienols. Apprehensions related to toxic chemicals in products such as food products, beverages, pharmaceuticals and personal care have driven the rapid growth in sales of natural vitamin E. Supplements for nutrition and food & beverage enrichment are the present primary markets for natural vitamin E, while, personal care and animal nutrition are anticipated to be potential markets in the near future.

Browse the full report with request TOC at http://www.transparencymarketresearch.com/natural-source-vitamin-e-market.html

Regionally, North America, especially U.S. is the largest market for natural source vitamin E. Europe also has a large market for natural source vitamin E, especially Germany, France, Italy, Spain and UK. Asia Pacific constitutes the fastest growing market led by China, India & Japan. The drivers for this market can be enlisted as the growing awareness among people about the benefits of natural source vitamins and different companies offering different range of healthy products which contain vitamins. Some companies (PepsiCo, Sunmagic, Aptitude Life Ltd.) have launched health drinks containing vitamin E and a few have launched biscuits containing vitamins. Thus change in the options of consuming vitamins has given these nutrients a boost in market. The challenge for this market lies in supply-demand disproportion for raw materials to a certain extent. The opportunities lie in deploying more technological innovations to maintain the global supply chains thus reducing the raw material procurement cost would lead to a profitable business proposition.

Some of the major players in this market are Beijing Gingko Group, BASF Corporation, BTSA, COFCO Tech Bioengineering, Carotech Bhd, Davos Life Science, Fenchem Biotek, Vitae Naturals, Eisai Food & Chemical, Ranbaxy, PepsiCo DSM Nutritional Products and Archer Daniels Midland Company.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World 

This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Angiogenesis Inhibitors And Stimulators Market - 2013 - 2019

Angiogenesis is a physiological process that is associated withthe formation of new blood vessel from existing blood vessels. Angiogenesis process is commonly categorized into two types namely sprouting angiogenesis and intussusceptive angiogenesis. Sprouting angiogenesis is a fundamental mechanism of vessel growth in which formation of new blood vessel is regulated by sequential steps. Intussusceptive angiogenesis (also called as splitting angiogenesis) is referred where new blood vessel is created by internal division of an existing blood vessel.


In contrast to sprouting angiogenesis, intussusceptive do not need local endothelial cell proliferation. Angiogenesis is mainly associated with the diverse set of conditions such as age related macular degradation, rheumatoid arthritis, cancer and psoriasis.The main focus of angiogenesis therapy is to shrink the existing tumor by aninhibitor or to meet the demand of under perfused region through generating new vessels by angiogenesis stimulator. Avastin (bevacizumab), Gleevec, Tarceva and Iressa are some of the largest selling angiogenesis inhibitor drugs worldwide.


Browse Full Report with TOC: http://www.transparencymarketresearch.com/angiogenesis-inhibitors-stimulators.html


Research and development activitiesfor the development of novel angiogenesis drugs for cancer treatment is the highest.Thus, increasing number of cancer cases will drive the growth of this market during the forecast period. According to World Health Organization, approximately 8.2 million deaths are reported in the year of 2012 due to cancer. Also it is predicted that, the annual cancer cases are expected rise from14 million to 22 million in next two decades. In addition, National Cancer Institute states that there are approximately 1,660,290 cases reported in the United States in 2013.Technological advancement will further boost the growth of angiogenesis inhibitor and stimulatorsmarket.For example, research in angiogenesis has enabled identification of several angiogenesis agonist and antagonist. However, high cost of these drugs will restrain the growth of this market.


Geographically, North America represents the largest market, followed by Europe for angiogenesis inhibitors and stimulatorsdue to large patient base and rise in treatment seeking population in these regions. The market of angiogenesis inhibitors and stimulators in Asia-Pacific countries such as India and China, South East Asian countries holds a strong growth as there is a rise in total number of newly diagnosed patient population of cancer in this region. According to World Health Organization, 60% of the world’s total annual cases of cancer occur in Africa, Asia and South America.


Some of the key players in the Angiogenesis Inhibitors and Stimulators market comprises Abbott Laboratories, Adnexus Therapeutics, Inc., F. Hoffman-La Roche, Ltd., Genentech, Inc., Amgen, Inc., AstraZeneca Plc., Novartis AG, Pfizer, Inc., Chugai Pharmaceutical Co., Ltd., EntreMed, Inc. and Eyetech, Inc.

 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

 Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future

·         It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030+1-518-618-1030

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

 

Browse Market Researche Report:-

http://www.tmrblog.com/

http://pharmaceuticalresearchreport.blogspot.com/

http://sandyresearcher.wordpress.com/

You'll need Skype CreditFree via Skype

Wednesday 12 March 2014

Drug Discovery Outsourcing Market - Global Industry Analysis, 2013 - 2019

Transparency Market Research
Transparency Market Research includes new market research report "Drug Discovery Outsourcing Market " to its huge collection of research reports.Drug discovery is a process of inventing a new medication in the field of pharmaceuticals, biotechnology and pharmacology. Drug discovery is a complex, lengthycomplicated and expensive process. This process is carried out in four stages namely, target identification, target validation, high-speed screening and lead optimization. Though advanced technologies are available, success rate of drug discovery is very low and the time involved is relatively high. 

Browse Full Report with TOC: 

Outsourcing of drug discovery saves time, cost and efforts of the pharmaceutical and biological companies. On the other hand companies providing outsourced services for drug discovery are equipped with developed infrastructure, highly developed technological front and skilled expertise. Rapidly progressing technologies, reduced turn-around time, increasing strategic partnerships and development of biosimilars, biologics and orphan drugs are some of the driving forces for the growth of the global drug discovery outsourcing market.Though the market scope for drug discovery outsourcing market is vast, increase in clinical research organizations (CROs), regional expansion, niche CROs and public-private partnerships is leading to increased competition that is restraining growth of this market. 

The final stage of drug discovery involves obtaining a patent and running clinical trials. Most of the drugs entering into clinical trials fail and obsolete from the trials thus leading to waste of time, cost and efforts. Generally, small pharmaceutical companies develop new drug molecules and sell patent rights to big companies that can afford to conduct clinical trials. In order to focus on core competencies such as manufacturing, marketing and product labeling many companies outsource their drug discovery processes. 

The market of drug discovery outsourcing is segmented depending on various types of services offered such as:

  • Biological services
  • Chemical services 
  • Lead Identification and screening  
  • Lead optimization 

Geographically, the global drug discovery outsourcing market can be categorized into North America, Europe, Asia-Pacific and rest of the world regions.North America currently leads this market and is followed by Europe due to existence and early adoption of highly developed technologies and supportive economy.

Especially countries like China and India are promising regions, reason being many small biopharmaceutical companies prefer outsourcing their drug discovery activities to CROs in China and India. Some of the market players in this industry segment are Galapagos NV, WIL Research Laboratories LLC, Albany Molecular Research, Inc. and Domainex, Ltd. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players.

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
More Reports On Pharmaceutical Market: - 

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Researche Report:-
http://marketingresearchreport.blogspot.com